Point72 Middle East Fze Dexcom Inc Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $10.3 Million - $16.9 Million	-135,790 Reduced 77.6%	39,190 $4.86 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $14.2 Million - $22.7 Million	164,713 Added 1604.3%	174,980 $16.3 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $4.32 Million - $5.03 Million	-38,433 Reduced 78.92%	10,267 $1.32 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $4.28 Million - $5.06 Million	-41,193 Reduced 45.82%	48,700 $5.66 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $7.64 Million - $11 Million	89,893 New	89,893 $0

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.